LIVE
Login☆ WatchlistAPI Docs
Markets
NSE StocksBSE StocksF&ORates & G-SecsCurrenciesSectorsCommodities
News
Corporate AnnouncementsGovernment & PolicyFixed IncomeETFsFXAlt. InvestingEconomic Calendar
Sections
EconomicsTechFinancePoliticsWealth
Language
Englishहिन्दीગુજરાતીमराठी

MARKSANS

NSEBSE
Marksans Pharma Limited
Healthcare· Pharmaceuticals & Biotechnology· INE750C01026· Scrip: 524404
ENहिन्दीગુજરાતીमराठी
184.80
2.96 (-1.58%)
30/4/2026, 3:28:56 pm
NSE
184.80
2.96
-1.58%
BSE
184.55
7.40
+0.00%
16018621323926504-2806-2408-2010-1712-1602-1304-2204-28
245 trading days · 1Y period
TODAY
Open187.00
High187.88
Low181.00
Prev Close187.76
Volume5.96L
Value₹11.0Cr
L: 181.00H: 187.88
52 WEEK
Low155.00
High270.70
26% of 52W range
Info
Face Value₹1
Listed2002-01-21
ISININE750C01026
SeriesA
BSE Scrip524404

Key Metrics

1D
-3.89%
1W
+4.46%
1M
+14.40%
3M
+6.99%
6M
+2.18%
Valuation
Mkt Cap₹7609 Cr
Growth (QoQ)
Revenue+6.22%
PAT+7.47%
EPS+8.45%
Profitability
Dividend
Yield0.43%
Growth+33.33%
TTM Revenue
₹2138 Cr
TTM EBITDA
₹479 Cr
TTM PAT
₹312 Cr
TTM EPS
₹6.88
Rev/Share
₹47.2

Quarterly Financials

Revenue
EBITDA
PAT
EPS
0 Cr170 Cr341 Cr511 Cr682 Cr22-1223-0323-0923-1224-0324-0624-0924-121.62.01.81.81.70.72.12.3
QuarterRevenueExpensesEBITDAPBTPATEPS
2024-12-31682 Cr566 Cr164 Cr143 Cr105 Cr2.31
2024-09-30642 Cr528 Cr144 Cr125 Cr98 Cr2.13
2024-06-30255 Cr220 Cr49 Cr42 Cr32 Cr0.71
2024-03-31560 Cr476 Cr121 Cr100 Cr78 Cr1.73
2023-12-31586 Cr478 Cr135 Cr113 Cr83 Cr1.84
2023-09-30531 Cr436 Cr131 Cr114 Cr84 Cr1.84
2023-03-31486 Cr393 Cr118 Cr104 Cr83 Cr1.97
2022-12-31480 Cr418 Cr92 Cr79 Cr62 Cr1.56

Shareholding Pattern

CURRENT2026-03-31
43.9%PROMOTER
Promoter43.9%
FII16.8%
DII6.6%
Public56.1%
PROMOTER HOLDING TREND
43.9%24-0643.9%24-0943.9%24-1243.9%25-0343.9%25-0943.9%25-1243.9%26-03

Corporate Actions

Ex-DateTypePurpose
2025-08-01DividendDividend - Re 0.80 Per Share
2024-09-17DividendDividend - Rs 0.60 Per Share
2023-06-07DividendDividend - Re 0.50 Per Share
2022-08-19DividendAnnual General Meeting/Dividend - Rs 0.25 Per Share
2021-09-15Dividend Annual General Meeting/Dividend - Rs 0.25 Per Share
2021-07-01Other Extra-Ordinary General Meeting
2020-09-22Dividend Annual General Meeting/Dividend - Rs 0.10 Per Share
2019-09-19Dividend Annual General Meeting/Dividend - Rs 0.05 Per Share
2018-09-19Dividend Annual General Meeting/Dividend Re 0.05 Per Share
2017-09-19Dividend Annual General Meeting/Dividend - Re 0.05 Per Share
2016-09-22Dividend Annual General Meeting/Dividend - Re 0.12 Per Share
2015-09-23Dividend Annual General Meeting/ Dividend - Re 0.12/- Per Share
2014-09-18DividendAnnual General Meeting / Dividend - Re 0.10/- Per Share
2013-09-19OtherAnnual General Meeting
2012-09-20OtherAnnual General Meeting
2011-09-22OtherAnnual General Meeting
2010-09-22OtherAnnual General Meeting
2009-09-17OtherAnnual General Meeting
2008-09-23OtherAnnual General Meeting
2008-03-11SplitFv Split Rs.10/- To Re.1/

Earnings Transcripts

Marksans Pharma Limited has informed the Exchange about Investor Presentation
13 Nov 2025NSE40K chars
Read →
Marksans Pharma Limited has informed the Exchange about Schedule of a conference call for analysts ...
31 Oct 2025NSE2K chars
Read →
Marksans Pharma Limited has informed the Exchange about Investor Presentation
12 Aug 2025NSE37K chars
Read →
Marksans Pharma Limited has informed the Exchange about Investor Presentation
19 May 2025NSE37K chars
Read →
Marksans Pharma Limited has informed the Exchange about Investor Presentation
11 Feb 2025NSE35K chars
Read →
Marksans Pharma Limited has informed the Exchange about Investor Presentation
9 Nov 2023NSE25K chars
Read →
Marksans Pharma Limited has informed the Exchange about Link of Recording of Q1 Financial Results Co...
17 Aug 2023NSE1K chars
Read →
Marksans Pharma Limited has informed the Exchange about Investor Presentation
30 May 2023NSE51K chars
Read →
Marksans Pharma Limited has informed the Exchange about Investor Presentation
13 Feb 2023NSE50K chars
Read →
Marksans Pharma Limited has informed the Exchange that Earnings Conference Call has been preponed to...
7 Feb 2023NSE2K chars
Read →
Marksans Pharma Limited has informed the Exchange about Transcript of Analysts/Institutional Investo...
21 Nov 2022NSE44K chars
Read →
Marksans Pharma Limited has informed the Exchange about Investor Presentation
14 Nov 2022NSE50K chars
Read →
Marksans Pharma Limited has informed the Exchange about Transcript of Analysts/Institutional Investo...
19 Aug 2022NSE46K chars
Read →
Marksans Pharma Limited has informed the Exchange about Investor Presentation
13 Aug 2022NSE46K chars
Read →
Marksans Pharma Limited has informed the Exchange about Schedule of Q1FY23 Earnings Call.
9 Aug 2022NSE2K chars
Read →
Marksans Pharma Limited has informed the Exchange about Transcript of Analysts/Institutional Investo...
6 Jun 2022NSE34K chars
Read →
Marksans Pharma Limited has informed the Exchange about Investor Presentation
30 May 2022NSE35K chars
Read →
Marksans Pharma Limited has informed the Exchange about Schedule of Q4&FY22 Results Conference Call.
24 May 2022NSE2K chars
Read →
Marksans Pharma Limited has informed the Exchange about Investor Presentation
11 Feb 2022NSE33K chars
Read →
Marksans Pharma Limited has informed the Exchange about Schedule of Conference Call with Seven Canyo...
17 Dec 2021NSE1K chars
Read →

Price History

DateOpenHighLowCloseVolume
2026-04-28191.99193.06183.11184.1010.98L
2026-04-27191.00195.00190.24192.128.15L
2026-04-24195.00195.00187.00190.2114.79L
2026-04-23178.00195.68177.67193.2543.79L
2026-04-22176.20180.11175.85179.565.75L
2026-04-21177.09178.90175.53176.776.88L
2026-04-20179.23179.23175.21176.905.50L
2026-04-17181.90181.90178.30179.236.06L
2026-04-16180.00181.99176.95180.184.83L
2026-04-15177.00180.72176.05178.926.10L
2026-04-13173.00178.25171.50176.144.96L
2026-04-10177.20180.50175.45178.484.99L
2026-04-09176.00178.50173.39174.985.50L
2026-04-08176.00176.00172.00174.606.46L
2026-04-07166.80171.30162.91170.008.41L
2026-04-02163.66169.17160.60168.155.51L
2026-04-01165.00171.48160.82168.049.18L
2026-03-27164.05165.50160.50163.0810.86L
2026-03-25165.35168.30163.60165.208.14L
2026-03-24163.00167.99159.70164.5413.06L
2026-03-20162.33171.80162.25170.0511.45L
2026-03-19167.00167.30161.01161.414.25L
2026-03-18164.90169.75164.59167.896.41L
2026-03-17164.76166.00163.50163.974.61L
2026-03-16167.84168.24162.68164.765.90L
2026-03-13170.84172.89165.74167.018.78L
2026-03-12171.82174.35169.48173.184.94L
2026-03-11174.06178.00171.00172.953.68L
2026-03-10170.00174.90170.00174.064.10L
2026-03-09167.00169.98165.25168.443.95L

Frequently Asked Questions

About

Marksans Pharma Limited is an Indian pharmaceutical company with a global presence, specializing in the research, manufacturing, and marketing of finished dosage forms. Key products include formulations for cardiovascular, central nervous system, and metabolic disorders. Notably, the company has a market capitalization of approximately ₹72.6 billion as of recent data.

Advertisement
BOARD OF DIRECTORS
Mark Saldanha
Managing Director
Vinay Gopal Nayak
Whole-time Director
DEPARTED
Abhinna Sundar Mohanty
Independent Director
Digant Mahesh Parikh
Independent Director
Meena Rani Surana
Independent Director
Seetharama Raju Buddharaju
Independent Director
DEPARTED
DEPARTED